'No Prejudice, No Hype': Florence Butlen-Ducuing on Europe's psychedelic renaissance, EMA experience, and cancer palliative care potential
Europe's psychedelic renaissance is framed through Florence Butlen-Ducuing's experience spanning the European Medicines Agency and her current clinical work. Butlen-Ducuing discusses how trial design and regulatory considerations shape psychedelic drug development in Europe, including how psychedelic programs fit within the European framework. She also connects the renewed development momentum to clinical realities, highlighting potential roles for psychedelics in palliative care for cancer patients, and offers a perspective grounded in both psychiatry and neuroscience.
These entries start auto-generated and improve with human input. Your contributions help!
Published Sep 11, 2025 · Added Mar 6, 2026